Pharma Journalist -

AVEO Oncology and EUSA Pharma announced that EUSA Pharma, under its multi-territory licensing agreement with AVEO for FOTIVDA (tivozanib), has opted into the Phase 1/2 TiNivo study.…
Read More...

Labcyte Inc. announced that GSK has joined its consortium with AstraZeneca to combine acoustic liquid dispensing technology from Labcyte with Mass Spectrometry (MS) for use in high…
Read More...

MilliporeSigma announced the opening of its first BioReliance End-to-End Biodevelopment Center in the Asia Pacific (APAC) region. Located in Shanghai, China, the center will provide a…
Read More...

Provention Bio announced that it has entered into agreements with Janssen Pharmaceutica NV and Janssen Sciences Ireland UC to in-license two clinical-stage assets, PRV-6527…
Read More...

Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag, research suggests. The drug – known as melatonin – appeared to prevent pain…
Read More...

AstraZeneca announced that it has entered into an agreement with Aspen Global Incorporated under which AGI will now acquire the residual rights to the established anaesthetic medicines…
Read More...

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore (NUS) recently showed…
Read More...

Immunocore Limited announced an investment from the Bill & Melinda Gates Foundation to support the development of Immunocore's soluble TCR-based therapeutics for infectious…
Read More...

Regeneron Pharmaceuticals and Sanofi announced positive results from the Phase 3 CAFÉ study of DUPIXENT® (dupilumab) in adults with moderate-to-severe atopic dermatitis (AD) who are…
Read More...

Thrombolytic Science, LLC (TSI) announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving therapy aimed at the treatment of clot-induced diseases…
Read More...